News
Welcome to our new member MDsim!
We are delighted to welcome our new member MDsim! MDsim is a health-tech start-up, based in Luxembourg, active in the In-Silico Medicine.
Mapping the use of computational modelling and simulation in clinics: A survey
Computational modelling and simulation (CM&S) can be used in medicine to mimic biological processes with the goal of understanding pathophysiology, improving diagnosis, treatment, or the prevention of diseases). The Virtual Physiological Human Institute (VPHi) reached out to medical stakeholders to record their experiences and opinions on the use of CM&S in clinical practice.
Nathalie Virag is the new Avicenna International Affairs Working Group Leader!
Nathalie Virag, Ph.D is a Distinguished Scientist at Medtronic Corporate Technology & Innovation. She has more than 25 years of experience in the medical device industry and computer modeling.
Second release of Avicenna Glossary now available!
Second release with an extended list of definitions.
France Biotech is a new Avicenna Partner!
We are delighted to welcome France Biotech as a new Avicenna Partner
Pharmaceutical Strategy White Paper
"The potential of in silico approaches to streamline drug development" This position paper highlights the potential of in silico medicine, using computational modelling and simulation to aid drug discovery, development, and delivery. It calls for adaptation of in silico technology to be a standard practice to complement in vivo and in vitro approaches in healthcare through a collaborative ecosystem of stakeholders.
